Description: Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.
Home Page: nevro.com
1800 Bridge Parkway
Redwood City,
CA
94065
United States
Phone:
650 251 0005
Officers
Name | Title |
---|---|
Mr. Kevin R. Thornal | President, CEO & Director |
Mr. Roderick H. MacLeod | Senior VP & CFO |
Mr. Kashif Rashid J.D. | Senior VP of Corporate Development & Chief Legal Officer |
Mr. Greg Siller | Senior VP & Chief Commercial Officer |
Mr. Christofer Christoforou | Senior VP & COO |
Ms. Angeline C. McCabe | Vice President of Investor Relations & Corporate Communications |
Ms. Shana D. Ross M.B.A. | Senior VP & Chief Human Resources Officer |
Dr. David Caraway M.D., Ph.D. | Senior VP & Chief Medical Officer |
Mr. Peter A. Socarras | VP, General Counsel & Corporate Secretary |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0.5479 |
Price-to-Sales TTM: | 0.3461 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 1215 |